HomeCompareAKEMF vs MRK

AKEMF vs MRK: Dividend Comparison 2026

AKEMF yields 3125.00% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 AKEMF wins by $671129994531.49M in total portfolio value
10 years
AKEMF
AKEMF
● Live price
3125.00%
Share price
$0.06
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$671129994531.54M
Annual income
$631,385,036,709,602,400.00
Full AKEMF calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — AKEMF vs MRK

📍 AKEMF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodAKEMFMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, AKEMF + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
AKEMF pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

AKEMF
Annual income on $10K today (after 15% tax)
$265,625.00/yr
After 10yr DRIP, annual income (after tax)
$536,677,281,203,162,050.00/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, AKEMF beats the other by $536,677,281,203,153,700.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of AKEMF + MRK for your $10,000?

AKEMF: 50%MRK: 50%
100% MRK50/50100% AKEMF
Portfolio after 10yr
$335564997265.80M
Annual income
$315,692,518,354,806,140.00/yr
Blended yield
94.08%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

AKEMF
No analyst data
Altman Z
0.5
Piotroski
2/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

AKEMF buys
0
MRK buys
0
No recent congressional trades found for AKEMF or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricAKEMFMRK
Forward yield3125.00%2.76%
Annual dividend / share$2.00$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%32.7%
Portfolio after 10y$671129994531.54M$56.8K
Annual income after 10y$631,385,036,709,602,400.00$9,798.13
Total dividends collected$668387949552.09M$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: AKEMF vs MRK ($10,000, DRIP)

YearAKEMF PortfolioAKEMF Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$323,200$312,500.00$11,206$366.19+$312.0KAKEMF
2$9,785,076$9,439,252.34$12,650$502.35+$9.77MAKEMF
3$277,553,301$267,083,269.73$14,407$694.19+$277.54MAKEMF
4$7,377,174,866$7,080,192,833.29$16,585$967.82+$7377.16MAKEMF
5$183,768,932,842$175,875,355,735.99$19,342$1,363.89+$183768.91MAKEMF
6$4,291,154,924,863$4,094,522,166,721.47$22,913$1,947.19+$4291154.90MAKEMF
7$93,947,089,375,049$89,355,553,605,446.11$27,662$2,823.89+$93947089.35MAKEMF
8$1,928,821,062,478,821$1,828,297,676,847,517.80$34,159$4,173.35+$1928821062.44MAKEMF
9$37,144,820,394,336,210$35,080,981,857,483,870.00$43,337$6,308.80+$37144820394.29MAKEMF
10$671,129,994,531,542,100$631,385,036,709,602,400.00$56,776$9,798.13+$671129994531.49MAKEMF

AKEMF vs MRK: Complete Analysis 2026

AKEMFStock

Alaska Energy Metals Corporation explores and develops mineral resources in the United States and Canada. The company explores for nickel, copper, cobalt, platinum, palladium, gold, chrome, and iron. Its flagship property is the Nikolai project, which comprises the Eureka claim block consisting of 106 mining claims and the Canwell claim block consisting of 59 mining claims, located in Alaska, the United States. It also owns 100% interest in the Angliers-Belleterre project, which consists of 464 claims covering approximately 26,417.40 hectares in western Quebec, Canada. The company was formerly known as Millrock Resources Inc. and changed its name to Alaska Energy Metals Corporation in March 2023. Alaska Energy Metals Corporation was incorporated in 1979 and is headquartered in Vancouver, Canada.

Full AKEMF Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this AKEMF vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

AKEMF vs SCHDAKEMF vs JEPIAKEMF vs OAKEMF vs KOAKEMF vs MAINAKEMF vs JNJAKEMF vs ABBVAKEMF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.